KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Receivables - Net (2016 - 2026)

Amgen has reported Receivables - Net over the past 18 years, most recently at $9.1 billion for Q1 2026.

  • For Q1 2026, Receivables - Net rose 12.37% year-over-year to $9.1 billion; the TTM value through Mar 2026 reached $9.1 billion, up 12.37%, while the annual FY2025 figure was $9.6 billion, 41.11% up from the prior year.
  • Receivables - Net for Q1 2026 was $9.1 billion at Amgen, down from $9.6 billion in the prior quarter.
  • Over five years, Receivables - Net peaked at $9.6 billion in Q4 2025 and troughed at $5.1 billion in Q1 2022.
  • A 5-year average of $6.9 billion and a median of $6.8 billion in 2024 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: dropped 6.69% in 2024 and later skyrocketed 41.11% in 2025.
  • Year by year, Receivables - Net stood at $5.6 billion in 2022, then surged by 30.65% to $7.3 billion in 2023, then fell by 6.69% to $6.8 billion in 2024, then skyrocketed by 41.11% to $9.6 billion in 2025, then dropped by 4.51% to $9.1 billion in 2026.
  • Business Quant data shows Receivables - Net for AMGN at $9.1 billion in Q1 2026, $9.6 billion in Q4 2025, and $8.5 billion in Q3 2025.